Krystal Biotech (KRYS) Return on Capital Employed Growth (3y) (2020 - 2026)
Krystal Biotech (KRYS) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Krystal Biotech |
10.23 Bn |
9.41 Bn |
110.03 Mn |
4,240.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,240.00 |
| Dec 31, 2025 |
4,057.00 |
| Sep 30, 2025 |
3,801.00 |
| Jun 30, 2025 |
3,395.00 |
| Mar 31, 2025 |
2,958.00 |
| Dec 31, 2024 |
2,048.00 |
| Sep 30, 2024 |
1,701.00 |
| Jun 30, 2024 |
939.00 |
| Mar 31, 2024 |
270.00 |
| Dec 31, 2023 |
-305.00 |
| Mar 31, 2023 |
-1,670.00 |
| Dec 31, 2022 |
-1,636.00 |
| Sep 30, 2022 |
-1,381.00 |
| Jun 30, 2022 |
-891.00 |
| Mar 31, 2022 |
-584.00 |
| Dec 31, 2021 |
110.00 |
| Sep 30, 2021 |
522.00 |
| Jun 30, 2021 |
605.00 |
| Mar 31, 2021 |
231.00 |
| Dec 31, 2020 |
-176.00 |
